High Purity Pharmaceutical Qib 915087-33-1 Enzalutamide rau Kev Kho Mob Cancer
Khoomnpe | Enzalutamide |
Synonyms | 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide;TIAB SA 3100 |
CAS Nr. | 915087-33-1 |
Qhov tshwm sim | Dawb khoom |
Molecular Formula | C21H16F4N4O2S |
Molecular Luj | 464.44 ib |
Kev siv | Pharmaceutical Qib lossis Kev Tshawb Fawb Lub Hom Phiaj |
Ntim | Raws li koj qhov kev thov |
Cia | Khaws nyob rau hauv nruj, lub teeb-resistant ntim nyob rau hauv ib qhov chaw txias |
Khoom npe: Enzalutamide (MDV3100) CAS Nr .: 915087-33-1 | ||
Yam khoom | STANDARDS | TSEEM CEEB |
Kev piav qhia | Dawb khoom | Dawb khoom |
Kev txheeb xyuas | HNMR | Ua raws |
Cov ntsiab lus dej los ntawm KF | ≤ 0.5% | 0.2% |
Poob rau ziab | ≤ 1.0% | 0.2% |
Residue ntawm ignition | ≤ 0.5% | 0.10% |
Purity (HPLC) | ≥99.0% | 99.9% |
Xaus | Ua raws li specification. |
Cov ntaub ntawv tuam txhab
√ Kev tswj cov txheej txheem tag nrho hauv lub Hoobkas thiab cov kws tshaj lij cov neeg ua haujlwm; √ Zoo yog ib txwm peb xav txog sab saum toj, nruj QC system; √ 11 xyoo dhau los ntawm pab pawg muag khoom; √ Kev ywj pheej R & D lab; √ Ob qhov kev kos npe mus sij hawm ntev GMP kev cob qhia; √ Cov peev txheej nplua nuj ntawm ntau lub chaw ua haujlwm tsis ua haujlwm rau qhov project customized; √ Pab neeg ua haujlwm siab ua haujlwm nrog txoj hauv kev zoo ib yam.Sau koj cov lus ntawm no thiab xa tuaj rau peb